Related Experiment Video
Updated: Sep 3, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Occult Hepatitis B Virus Infection: An Update.
Carlo Saitta1,2, Teresa Pollicino3, Giovanni Raimondo1,2
1Division of Medicine and Hepatology, University Hospital of Messina, 98124 Messina, Italy.
Occult hepatitis B virus (HBV) infection means HBV DNA is present without surface antigen. This condition can spread, reactivate, worsen liver disease, and cause liver cancer.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Occult hepatitis B virus (HBV) infection (OBI) is characterized by detectable HBV DNA in the liver but undetectable HBV surface antigen (HBsAg) in serum.
- Viral replication in OBI is suppressed, primarily due to host immune responses and epigenetic factors.
- OBI prevalence varies globally, influenced by geography, transmission risks, and diagnostic methods.
Purpose of the Study:
- To elucidate the mechanisms suppressing viral activity in occult hepatitis B virus infection.
- To understand the clinical implications and transmission potential of occult hepatitis B virus infection.
Main Methods:
- The study reviews current understanding of OBI pathogenesis, focusing on immune control and epigenetic regulation.
- Analysis of factors influencing OBI prevalence, including geographical distribution and diagnostic assay sensitivity.
Main Results:
- Host immune control and epigenetic factors are key in suppressing HBV replication during occult infection.
- OBI poses risks for transmission via transfusion/transplantation, reactivation under immunosuppression, accelerated liver disease progression, and hepatocellular carcinoma development.
Conclusions:
- Occult hepatitis B virus infection is a significant clinical concern with implications for public health and patient management.
- Further research into OBI mechanisms and diagnostics is crucial for effective prevention and treatment strategies.
More Related Videos
11:14Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022